世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

2030年までの欧州抗ニキビ皮膚パッチ市場調査レポート予測


Europe Anti-Acne Dermal Patch Market Research Report Forecast to 2030

2030年までの欧州抗ニキビ皮膚パッチ市場予測 市場概要 欧州の抗ニキビ皮膚パッチ市場の成長は、欧州全域で尋常性ざ瘡の有病率が上昇していること、座りがちなライフスタイルや不健康な食習慣が増加しているこ... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Market Research Future
マーケットリサーチフューチャー (MRFR)
2023年8月10日 US$5,250
ライセンス・価格情報
注文方法はこちら
90 英語

 

サマリー

2030年までの欧州抗ニキビ皮膚パッチ市場予測
市場概要
欧州の抗ニキビ皮膚パッチ市場の成長は、欧州全域で尋常性ざ瘡の有病率が上昇していること、座りがちなライフスタイルや不健康な食習慣が増加していること、ソーシャルメディアやブランド推薦の影響力が高いことに起因している。しかし、発疹やアレルギーに関する懸念は、予測期間における市場の成長を妨げる可能性がある。とはいえ、消費者の間で化学物質を含まない製品の採用が進んでいることから、欧州の抗ニキビ皮膚パッチ市場で事業を展開する企業には有利な機会が生まれると予想される。
欧州の抗ニキビ皮膚パッチ市場は、欧州全体で尋常性ざ瘡の有病率が上昇していること、座りがちなライフスタイルや不健康な食習慣が増加していること、ソーシャルメディアやブランド推薦の影響力が高いことなどが原因で台頭している。さらに、消費者の間で化学物質を含まない製品の採用が拡大していることも、今後の市場に成長機会をもたらすだろう。しかし、かぶれやアレルギーに関する懸念が、予測期間中の市場の成長を妨げる可能性がある。
市場区分
ニキビのタイプに基づき、欧州の抗ニキビ皮膚パッチ市場は炎症性ニキビと非炎症性ニキビに区分される。
パッチタイプに基づき、欧州の抗ニキビ皮膚パッチ市場は薬用、非薬用、マイクロニードルにセグメント化される。薬用はさらにハイドロコロイド系、サリチル酸系、ヒアルロン酸系に区分される。
成分タイプに基づき、欧州の抗ニキビ皮膚パッチ市場は化学ベースとハーブベースに区分される。販売チャネルに基づき、欧州の抗ニキビ皮膚パッチ市場は小売店、薬局&ドラッグストア、eコマースプラットフォームに区分される。
欧州地域は、ドイツ、フランス、英国、イタリア、スペイン、その他の欧州諸国などで構成されている。欧州地域は、男性におけるタバコの煙の消費量の多さ、女性における尋常性ざ瘡の有病率の増加、女性における多嚢胞性卵巣症候群、糖尿病、肥満などの併存疾患の有病率の増加など、いくつかの要因によって牽引されている。2021年にはドイツが市場を席巻し、2022~2030年の予測期間中にはフランスが最も急成長すると予測されている。
主要プレーヤー
3M(米国)、Church & Dwight Co Inc(米国)、EcoFeminii Ltd(米国)、Avalon Natural Products, Inc(米国)、ZitSticka(米国)、Mario Badescu Skin Care Inc(米国)、Starface(米国)、Peace Out LLC(米国)、COSRX(韓国)、Peach & Lilly(米国)が市場の主要プレーヤーである。

ページTOPに戻る


目次

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 12
1.1 OVERVIEW 12
2 MARKET INTRODUCTION 13
2.1 DEFINITION 13
2.2 SCOPE OF THE STUDY 13
2.3 RESEARCH OBJECTIVE 13
2.4 MARKET STRUCTURE 14
2.5 ASSUMPTIONS & LIMITATIONS 15
3 RESEARCH METHODOLOGY 16
3.1 DATA MINING 16
3.2 SECONDARY RESEARCH 17
3.3 PRIMARY RESEARCH 18
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 19
3.5 FORECASTING TECHNIQUES 20
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21
3.6.1 BOTTOM-UP APPROACH 22
3.6.2 TOP-DOWN APPROACH 22
3.7 DATA TRIANGULATION 22
3.8 VALIDATION 23
4 MARKET DYNAMICS 24
4.1 OVERVIEW 24
4.2 DRIVERS 25
4.2.1 RISING PREVALENCE OF ACNE VULGARIS ACROSS EUROPE 25
4.2.2 INCREASING SEDENTARY LIFESTYLE AND UNHEALTHY FOOD HABITS 25
4.2.3 HIGH INFLUENCE OF SOCIAL MEDIA AND BRAND ENDORSEMENTS 25
4.3 RESTRAINTS 26
4.3.1 CONCERNS PERTAINING TO RASHES AND ALLERGIES 26
4.4 OPPORTUNITY 27
4.4.1 GROWING ADOPTION OF CHEMICAL-FREE PRODUCTS AMONG CONSUMERS 27
5 MARKET FACTOR ANALYSIS 28
5.1 VALUE CHAIN ANALYSIS 28
5.1.1 R&D 29
5.1.2 MANUFACTURING 29
5.1.3 MARKETING AND DISTRIBUTION 29
5.1.4 POST-SALES MONITORING 29
5.2 PORTER'S FIVE FORCES MODEL 30
5.2.1 THREAT OF NEW ENTRANTS 30
5.2.2 BARGAINING POWER OF SUPPLIERS 31
5.2.3 THREAT OF SUBSTITUTES 31
5.2.4 BARGAINING POWER OF BUYERS 31
5.2.5 INTENSITY OF RIVALRY 31
5.3 IMPACT OF COVID-19 ON THE EUROPE ANTI-ACNE DERMAL PATCH MARKET 32
6 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE 33
6.1 OVERVIEW 33
6.2 INFLAMMATORY ACNE 34
6.3 NON-INFLAMMATORY ACNE 35
7 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE 36
7.1 OVERVIEW 36
7.2 MEDICATED 37
7.3 NON-MEDICATED 38
7.4 MICRO-NEEDLE 38
8 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE 39
8.1 OVERVIEW 39
8.2 CHEMICAL BASED 40
8.2.1 HYDROCOLLOID BASED 41
8.2.2 SALICYLIC ACID BASED 42
8.2.3 HYALURONIC ACID BASED 42
8.3 HERBAL BASED 43
9 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL 44
9.1 OVERVIEW 44
9.2 RETAIL STORES 46
9.3 PHARMACIES & DRUG STORES 46
9.4 E-COMMERCE PLATFORM 47
10 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY COUNTRY 48
10.1 OVERVIEW 48
10.1.1 GERMANY 52
10.1.2 FRANCE 54
10.1.3 UK 56
10.1.4 ITALY 58
10.1.5 SPAIN 60
10.1.6 REST OF EUROPE 63
11 COMPETITIVE LANDSCAPE 65
11.1 OVERVIEW 65
11.2 COMPETITIVE BENCHMARKING 66
11.3 MAJOR GROWTH STRATEGY IN THE EUROPE ANTI-ACNE DERMAL PATCH MARKET 67
11.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE EUROPE ANTI-ACNE DERMAL PATCH MARKET 68
11.5 KEY DEVELOPMENT ANALYSIS 68
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 69
11.6.1 PRODUCT APPROVAL AND PRODUCT LAUNCHES 69
11.6.2 ACQUISITION 69
11.7 FINANCIAL MATRIX 69
11.7.1 SALES (USD MILLION), 2021 69
11.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2021 70
12 COMPANY PROFILES 71
12.1 3M 71
12.1.1 COMPANY OVERVIEW 71
12.1.2 FINANCIAL OVERVIEW 72
12.1.3 PRODUCTS OFFERED 72
12.1.4 KEY DEVELOPMENTS 73
12.1.5 SWOT ANALYSIS 73
12.1.6 KEY STRATEGIES 73
12.2 ECOFEMINII LTD. 74
12.2.1 COMPANY OVERVIEW 74
12.2.2 FINANCIAL OVERVIEW 74
12.2.3 PRODUCTS OFFERED 74
12.2.4 KEY DEVELOPMENTS 74
12.2.5 KEY STRATEGIES 74
12.3 AVALON NATURAL PRODUCTS, INC. 75
12.3.1 COMPANY OVERVIEWS 75
12.3.2 FINANCIAL OVERVIEW 75
12.3.3 PRODUCTS OFFERED 75
12.3.4 KEY DEVELOPMENTS 75
12.3.5 SWOT ANALYSIS 76
12.3.6 KEY STRATEGIES 76
12.4 ZITSTICKA 77
12.4.1 COMPANY OVERVIEW 77
12.4.2 FINANCIAL OVERVIEW 77
12.4.3 PRODUCTS OFFERED 77
12.4.4 KEY DEVELOPMENTS 77
12.4.5 KEY STRATEGIES 78
12.5 MARIO BADESCU SKIN CARE, INC. 79
12.5.1 COMPANY OVERVIEW 79
12.5.2 FINANCIAL OVERVIEW 79
12.5.3 PRODUCTS OFFERED 79
12.5.4 KEY DEVELOPMENTS 79
12.5.5 KEY STRATEGIES 79
12.6 CHURCH & DWIGHT CO., INC 80
12.6.1 COMPANY OVERVIEWS 80
12.6.2 FINANCIAL OVERVIEW 80
12.6.3 PRODUCTS OFFERED 81
12.6.4 KEY DEVELOPMENTS 81
12.6.5 SWOT ANALYSIS 81
12.6.6 KEY STRATEGIES 82
12.7 STARFACE 83
12.7.1 COMPANY OVERVIEW 83
12.7.2 FINANCIAL OVERVIEW 83
12.7.3 PRODUCTS OFFERED 83
12.7.4 STARFACE: KEY DEVELOPMENTS 83
12.7.5 SWOT ANALYSIS 84
12.7.6 KEY STRATEGIES 84
12.8 PEACE OUT, LLC 85
12.8.1 COMPANY OVERVIEW 85
12.8.2 FINANCIAL OVERVIEW 85
12.8.3 PRODUCTS OFFERED 85
12.8.4 KEY DEVELOPMENTS 85
12.8.5 SWOT ANALYSIS 86
12.8.6 KEY STRATEGIES 86
12.9 COSRX 87
12.9.1 COMPANY OVERVIEW 87
12.9.2 FINANCIAL OVERVIEW 87
12.9.3 PRODUCTS OFFERED 87
12.9.4 KEY DEVELOPMENTS 87
12.9.5 KEY STRATEGIES 87
12.10 PEACH & LILLY 88
12.10.1 COMPANY OVERVIEW 88
12.10.2 FINANCIAL OVERVIEW 88
12.10.3 PRODUCTS OFFERED 88
12.10.4 KEY DEVELOPMENTS 88
12.10.5 KEY STRATEGIES 88
13 APPENDIX 89
13.1 REFERENCES 89
13.1.1 EUROPEAN SOCIETY FOR DERMATOLOGY AND PSYCHIATRY 89
13.1.2 EUROPEAN DERMATOLOGY FORUM 89
13.1.3 THE EUROPEAN SOCIETY FOR DERMATOLOGICAL RESEARCH (ESDR) 89
13.1.4 EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 89
13.1.5 EUROPEAN SOCIETY FOR COSMETIC AND AESTHETIC DERMATOLOGY 89
13.1.6 BRITISH ASSOCIATION OF DERMATOLOGISTS 89
13.1.7 FRENCH SOCIETY OF DERMATOLOGY 89
13.1.8 THE ITALIAN SOCIETY OF DERMATOLOGY 89
13.1.9 SPANISH ASSOCIATION OF DERMATOLOGY AND VENEREOLOGY 89
13.1.10 BRITISH ASSOCIATION OF DERMATOLOGISTS 89
13.2 RELATED REPORTS 89
?

ページTOPに戻る



図表リスト

LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 15
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 18
TABLE 3 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR BY ACNE TYPE, 2018?2030 (USD MILLION) 34
TABLE 4 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR INFLAMMATORY ACNE, BY COUNTRY, 2018?2030 (USD MILLION) 34
TABLE 5 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR NON-INFAMMATORY ACNE, BY COUNTRY, 2018?2030 (USD MILLION) 35
TABLE 6 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR BY PATCH TYPE, 2018?2030 (USD MILLION) 37
TABLE 7 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR MEDICATED, BY COUNTRY, 2018?2030 (USD MILLION) 37
TABLE 8 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR NON-MEDICATED, BY COUNTRY, 2018?2030 (USD MILLION) 38
TABLE 9 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR MICRO-NEEDLE, BY COUNTRY, 2018?2030 (USD MILLION) 38
TABLE 10 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR BY INGREDIENT TYPE, 2018?2030 (USD MILLION) 40
TABLE 11 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY COUNTRY, 2018?2030 (USD MILLION) 40
TABLE 12 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018?2030 (USD MILLION) 40
TABLE 13 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR HYDROCOLLOID BASED, BY COUNTRY, 2018?2030 (USD MILLION) 41
TABLE 14 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR SALICYLIC ACID BASED, BY COUNTRY, 2018?2030 (USD MILLION) 42
TABLE 15 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR HYALURONIC ACID BASED, BY COUNTRY, 2018?2030 (USD MILLION) 42
TABLE 16 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR NON-MEDICATED, BY COUNTRY, 2018?2030 (USD MILLION) 43
TABLE 17 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018?2030 (USD MILLION) 45
TABLE 18 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR RETAIL STORES, BY COUNTRY, 2018?2030 (USD MILLION) 46
TABLE 19 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR PHARMACIES & DRUG STORES, BY COUNTRY, 2018?2030 (USD MILLION) 46
TABLE 20 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR E-COMMERCE PLATFORM, BY COUNTRY, 2018?2030 (USD MILLION) 47
TABLE 21 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY COUNTRY, 2018?2030 (USD MILLION) 49
TABLE 22 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2018?2030 (USD MILLION) 50
TABLE 23 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2018?2030 (USD MILLION) 50
TABLE 24 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2018?2030 (USD MILLION) 50
TABLE 25 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018?2030 (USD MILLION) 51
TABLE 26 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018?2030 (USD MILLION) 51
TABLE 27 GERMANY ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2018?2030 (USD MILLION) 52
TABLE 28 GERMANY ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2018?2030 (USD MILLION) 53
TABLE 29 GERMANY ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2018?2030 (USD MILLION) 53
TABLE 30 GERMANY ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018?2030 (USD MILLION) 53
TABLE 31 GERMANY ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018?2030 (USD MILLION) 54
TABLE 32 FRANCE ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2018?2030 (USD MILLION) 54
TABLE 33 FRANCE ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2018?2030 (USD MILLION) 54
TABLE 34 FRANCE ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2018?2030 (USD MILLION) 55
TABLE 35 FRANCE ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018?2030 (USD MILLION) 55
TABLE 36 FRANCE ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018?2030 (USD MILLION) 56
TABLE 37 UK ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2018?2030 (USD MILLION) 56
TABLE 38 UK ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2018?2030 (USD MILLION) 56
TABLE 39 UK ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2018?2030 (USD MILLION) 57
TABLE 40 UK ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018?2030 (USD MILLION) 57
TABLE 41 UK ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018?2030 (USD MILLION) 58
TABLE 42 ITALY ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2018?2030 (USD MILLION) 58
TABLE 43 ITALY ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2018?2030 (USD MILLION) 59
TABLE 44 ITALY ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2018?2030 (USD MILLION) 59
TABLE 45 ITALY ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018?2030 (USD MILLION) 59
TABLE 46 ITALY ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018?2030 (USD MILLION) 60
TABLE 47 SPAIN ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2018?2030 (USD MILLION) 61
TABLE 48 SPAIN ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2018?2030 (USD MILLION) 61
TABLE 49 SPAIN ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2018?2030 (USD MILLION) 61
TABLE 50 SPAIN ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018?2030 (USD MILLION) 62
TABLE 51 SPAIN ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018?2030 (USD MILLION) 62
TABLE 52 REST OF EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2018?2030 (USD MILLION) 63
TABLE 53 REST OF EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2018?2030 (USD MILLION) 63
TABLE 54 REST OF EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2018?2030 (USD MILLION) 64
TABLE 55 REST OF EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018?2030 (USD MILLION) 64
TABLE 56 REST OF EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018?2030 (USD MILLION) 64
TABLE 57 MAJOR PLAYERS IN THE EUROPE ANTI-ACNE DERMAL PATCH MARKET 65
TABLE 58 MOST ACTIVE PLAYER IN THE EUROPE ANTI-ACNE DERMAL PATCH MARKET 68
TABLE 59 PRODUCT APPROVAL AND PRODUCT LAUNCHES 69
TABLE 60 ACQUISITION 69
TABLE 61 3M: PRODUCTS OFFERED 72
TABLE 62 ECOFEMINII LTD.: PRODUCTS OFFERED 74
TABLE 63 AVALON NATURAL PRODUCTS, INC.: PRODUCTS OFFERED 75
TABLE 64 ZITSTICKA: PRODUCTS OFFERED 77
TABLE 65 ZITSTICKA: KEY DEVELOPMENTS 77
TABLE 66 MARIO BADESCU SKIN CARE, INC.: PRODUCTS OFFERED 79
TABLE 67 CHURCH & DWIGHT CO., INC.: PRODUCTS OFFERED 81
TABLE 68 CHURCH & DWIGHT CO., INC: KEY DEVELOPMENTS 81
TABLE 69 STARFACE: PRODUCTS OFFERED 83
TABLE 70 PEACE OUT LLC: PRODUCTS OFFERED 85
TABLE 71 COSRX: PRODUCTS OFFERED 87
TABLE 72 PEACH & LILLY: PRODUCTS OFFERED 88

?

 

ページTOPに戻る


 

Summary

Europe Anti-Acne Dermal Patch Market Research Report Forecast to 2030
Market Overview
The growth of the Europe anti-acne dermal patch market is attributed to the rising prevalence of acne vulgaris across Europe, increasing sedentary lifestyles and unhealthy food habits, and the high influence of social media and brand endorsements. However, the concerns pertaining to rashes and allergies might hamper the market's growth in the forecast period. Nevertheless, it is anticipated that the growing adoption of chemical-free products among consumers will create lucrative opportunities for the players operating in the European anti-acne dermal patch market.
The Europe anti-acne dermal patch market is emerging due to the rising prevalence of acne vulgaris across Europe, increasing sedentary lifestyles and unhealthy food habits, and the high influence of social media and brand endorsements. Additionally, the growing adoption of chemical-free products among consumers will provide growth opportunities for the market in the future. However, the concerns pertaining to rashes and allergies might hamper the market's growth in the forecast period.
Market Segmentation
Based on acne type, the Europe anti-acne dermal patch market has been segmented into inflammatory and non-inflammatory acne.
Based on patch type, the Europe anti-acne dermal patch market has been segmented into medicated, non-medicated, and micro-needle. Medicated further segmented into hydrocolloid based, salicylic acid-based, and hyaluronic acid-based.
Based on ingredient type, the Europe anti-acne dermal patch market has been segmented into chemical based and herbal-based. Based on the distribution channel, the Europe anti-acne dermal patch market has been segmented into retail stores, pharmacies & drug stores, and e-commerce platforms.
The Europe region is comprised of countries including Germany, France, the UK, Italy, Spain, and the Rest of Europe. The Europe region is driven by several factors, including high consumption of cigarette smoke among men, an increasing prevalence of acne vulgaris among women, and an increasing prevalence of comorbid diseases such as polycystic ovary syndrome, diabetes, and obesity among women. Germany country dominated the market in 2021 and France is projected to be the fastest-growing during the forecast period, 2022–2030.
Major Players
3M (US), Church & Dwight Co Inc (US), EcoFeminii Ltd (US), Avalon Natural Products, Inc (US), ZitSticka (US), Mario Badescu Skin Care Inc (US), Starface (US), Peace Out LLC (US), COSRX (South Korea), and Peach & Lilly (US) are key players in the market.



ページTOPに戻る


Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 12
1.1 OVERVIEW 12
2 MARKET INTRODUCTION 13
2.1 DEFINITION 13
2.2 SCOPE OF THE STUDY 13
2.3 RESEARCH OBJECTIVE 13
2.4 MARKET STRUCTURE 14
2.5 ASSUMPTIONS & LIMITATIONS 15
3 RESEARCH METHODOLOGY 16
3.1 DATA MINING 16
3.2 SECONDARY RESEARCH 17
3.3 PRIMARY RESEARCH 18
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 19
3.5 FORECASTING TECHNIQUES 20
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21
3.6.1 BOTTOM-UP APPROACH 22
3.6.2 TOP-DOWN APPROACH 22
3.7 DATA TRIANGULATION 22
3.8 VALIDATION 23
4 MARKET DYNAMICS 24
4.1 OVERVIEW 24
4.2 DRIVERS 25
4.2.1 RISING PREVALENCE OF ACNE VULGARIS ACROSS EUROPE 25
4.2.2 INCREASING SEDENTARY LIFESTYLE AND UNHEALTHY FOOD HABITS 25
4.2.3 HIGH INFLUENCE OF SOCIAL MEDIA AND BRAND ENDORSEMENTS 25
4.3 RESTRAINTS 26
4.3.1 CONCERNS PERTAINING TO RASHES AND ALLERGIES 26
4.4 OPPORTUNITY 27
4.4.1 GROWING ADOPTION OF CHEMICAL-FREE PRODUCTS AMONG CONSUMERS 27
5 MARKET FACTOR ANALYSIS 28
5.1 VALUE CHAIN ANALYSIS 28
5.1.1 R&D 29
5.1.2 MANUFACTURING 29
5.1.3 MARKETING AND DISTRIBUTION 29
5.1.4 POST-SALES MONITORING 29
5.2 PORTER'S FIVE FORCES MODEL 30
5.2.1 THREAT OF NEW ENTRANTS 30
5.2.2 BARGAINING POWER OF SUPPLIERS 31
5.2.3 THREAT OF SUBSTITUTES 31
5.2.4 BARGAINING POWER OF BUYERS 31
5.2.5 INTENSITY OF RIVALRY 31
5.3 IMPACT OF COVID-19 ON THE EUROPE ANTI-ACNE DERMAL PATCH MARKET 32
6 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE 33
6.1 OVERVIEW 33
6.2 INFLAMMATORY ACNE 34
6.3 NON-INFLAMMATORY ACNE 35
7 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE 36
7.1 OVERVIEW 36
7.2 MEDICATED 37
7.3 NON-MEDICATED 38
7.4 MICRO-NEEDLE 38
8 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE 39
8.1 OVERVIEW 39
8.2 CHEMICAL BASED 40
8.2.1 HYDROCOLLOID BASED 41
8.2.2 SALICYLIC ACID BASED 42
8.2.3 HYALURONIC ACID BASED 42
8.3 HERBAL BASED 43
9 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL 44
9.1 OVERVIEW 44
9.2 RETAIL STORES 46
9.3 PHARMACIES & DRUG STORES 46
9.4 E-COMMERCE PLATFORM 47
10 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY COUNTRY 48
10.1 OVERVIEW 48
10.1.1 GERMANY 52
10.1.2 FRANCE 54
10.1.3 UK 56
10.1.4 ITALY 58
10.1.5 SPAIN 60
10.1.6 REST OF EUROPE 63
11 COMPETITIVE LANDSCAPE 65
11.1 OVERVIEW 65
11.2 COMPETITIVE BENCHMARKING 66
11.3 MAJOR GROWTH STRATEGY IN THE EUROPE ANTI-ACNE DERMAL PATCH MARKET 67
11.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE EUROPE ANTI-ACNE DERMAL PATCH MARKET 68
11.5 KEY DEVELOPMENT ANALYSIS 68
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 69
11.6.1 PRODUCT APPROVAL AND PRODUCT LAUNCHES 69
11.6.2 ACQUISITION 69
11.7 FINANCIAL MATRIX 69
11.7.1 SALES (USD MILLION), 2021 69
11.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2021 70
12 COMPANY PROFILES 71
12.1 3M 71
12.1.1 COMPANY OVERVIEW 71
12.1.2 FINANCIAL OVERVIEW 72
12.1.3 PRODUCTS OFFERED 72
12.1.4 KEY DEVELOPMENTS 73
12.1.5 SWOT ANALYSIS 73
12.1.6 KEY STRATEGIES 73
12.2 ECOFEMINII LTD. 74
12.2.1 COMPANY OVERVIEW 74
12.2.2 FINANCIAL OVERVIEW 74
12.2.3 PRODUCTS OFFERED 74
12.2.4 KEY DEVELOPMENTS 74
12.2.5 KEY STRATEGIES 74
12.3 AVALON NATURAL PRODUCTS, INC. 75
12.3.1 COMPANY OVERVIEWS 75
12.3.2 FINANCIAL OVERVIEW 75
12.3.3 PRODUCTS OFFERED 75
12.3.4 KEY DEVELOPMENTS 75
12.3.5 SWOT ANALYSIS 76
12.3.6 KEY STRATEGIES 76
12.4 ZITSTICKA 77
12.4.1 COMPANY OVERVIEW 77
12.4.2 FINANCIAL OVERVIEW 77
12.4.3 PRODUCTS OFFERED 77
12.4.4 KEY DEVELOPMENTS 77
12.4.5 KEY STRATEGIES 78
12.5 MARIO BADESCU SKIN CARE, INC. 79
12.5.1 COMPANY OVERVIEW 79
12.5.2 FINANCIAL OVERVIEW 79
12.5.3 PRODUCTS OFFERED 79
12.5.4 KEY DEVELOPMENTS 79
12.5.5 KEY STRATEGIES 79
12.6 CHURCH & DWIGHT CO., INC 80
12.6.1 COMPANY OVERVIEWS 80
12.6.2 FINANCIAL OVERVIEW 80
12.6.3 PRODUCTS OFFERED 81
12.6.4 KEY DEVELOPMENTS 81
12.6.5 SWOT ANALYSIS 81
12.6.6 KEY STRATEGIES 82
12.7 STARFACE 83
12.7.1 COMPANY OVERVIEW 83
12.7.2 FINANCIAL OVERVIEW 83
12.7.3 PRODUCTS OFFERED 83
12.7.4 STARFACE: KEY DEVELOPMENTS 83
12.7.5 SWOT ANALYSIS 84
12.7.6 KEY STRATEGIES 84
12.8 PEACE OUT, LLC 85
12.8.1 COMPANY OVERVIEW 85
12.8.2 FINANCIAL OVERVIEW 85
12.8.3 PRODUCTS OFFERED 85
12.8.4 KEY DEVELOPMENTS 85
12.8.5 SWOT ANALYSIS 86
12.8.6 KEY STRATEGIES 86
12.9 COSRX 87
12.9.1 COMPANY OVERVIEW 87
12.9.2 FINANCIAL OVERVIEW 87
12.9.3 PRODUCTS OFFERED 87
12.9.4 KEY DEVELOPMENTS 87
12.9.5 KEY STRATEGIES 87
12.10 PEACH & LILLY 88
12.10.1 COMPANY OVERVIEW 88
12.10.2 FINANCIAL OVERVIEW 88
12.10.3 PRODUCTS OFFERED 88
12.10.4 KEY DEVELOPMENTS 88
12.10.5 KEY STRATEGIES 88
13 APPENDIX 89
13.1 REFERENCES 89
13.1.1 EUROPEAN SOCIETY FOR DERMATOLOGY AND PSYCHIATRY 89
13.1.2 EUROPEAN DERMATOLOGY FORUM 89
13.1.3 THE EUROPEAN SOCIETY FOR DERMATOLOGICAL RESEARCH (ESDR) 89
13.1.4 EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 89
13.1.5 EUROPEAN SOCIETY FOR COSMETIC AND AESTHETIC DERMATOLOGY 89
13.1.6 BRITISH ASSOCIATION OF DERMATOLOGISTS 89
13.1.7 FRENCH SOCIETY OF DERMATOLOGY 89
13.1.8 THE ITALIAN SOCIETY OF DERMATOLOGY 89
13.1.9 SPANISH ASSOCIATION OF DERMATOLOGY AND VENEREOLOGY 89
13.1.10 BRITISH ASSOCIATION OF DERMATOLOGISTS 89
13.2 RELATED REPORTS 89
?

ページTOPに戻る



List of Tables/Graphs

LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 15
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 18
TABLE 3 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR BY ACNE TYPE, 2018?2030 (USD MILLION) 34
TABLE 4 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR INFLAMMATORY ACNE, BY COUNTRY, 2018?2030 (USD MILLION) 34
TABLE 5 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR NON-INFAMMATORY ACNE, BY COUNTRY, 2018?2030 (USD MILLION) 35
TABLE 6 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR BY PATCH TYPE, 2018?2030 (USD MILLION) 37
TABLE 7 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR MEDICATED, BY COUNTRY, 2018?2030 (USD MILLION) 37
TABLE 8 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR NON-MEDICATED, BY COUNTRY, 2018?2030 (USD MILLION) 38
TABLE 9 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR MICRO-NEEDLE, BY COUNTRY, 2018?2030 (USD MILLION) 38
TABLE 10 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR BY INGREDIENT TYPE, 2018?2030 (USD MILLION) 40
TABLE 11 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY COUNTRY, 2018?2030 (USD MILLION) 40
TABLE 12 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018?2030 (USD MILLION) 40
TABLE 13 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR HYDROCOLLOID BASED, BY COUNTRY, 2018?2030 (USD MILLION) 41
TABLE 14 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR SALICYLIC ACID BASED, BY COUNTRY, 2018?2030 (USD MILLION) 42
TABLE 15 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR HYALURONIC ACID BASED, BY COUNTRY, 2018?2030 (USD MILLION) 42
TABLE 16 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR NON-MEDICATED, BY COUNTRY, 2018?2030 (USD MILLION) 43
TABLE 17 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018?2030 (USD MILLION) 45
TABLE 18 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR RETAIL STORES, BY COUNTRY, 2018?2030 (USD MILLION) 46
TABLE 19 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR PHARMACIES & DRUG STORES, BY COUNTRY, 2018?2030 (USD MILLION) 46
TABLE 20 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR E-COMMERCE PLATFORM, BY COUNTRY, 2018?2030 (USD MILLION) 47
TABLE 21 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY COUNTRY, 2018?2030 (USD MILLION) 49
TABLE 22 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2018?2030 (USD MILLION) 50
TABLE 23 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2018?2030 (USD MILLION) 50
TABLE 24 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2018?2030 (USD MILLION) 50
TABLE 25 EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018?2030 (USD MILLION) 51
TABLE 26 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018?2030 (USD MILLION) 51
TABLE 27 GERMANY ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2018?2030 (USD MILLION) 52
TABLE 28 GERMANY ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2018?2030 (USD MILLION) 53
TABLE 29 GERMANY ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2018?2030 (USD MILLION) 53
TABLE 30 GERMANY ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018?2030 (USD MILLION) 53
TABLE 31 GERMANY ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018?2030 (USD MILLION) 54
TABLE 32 FRANCE ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2018?2030 (USD MILLION) 54
TABLE 33 FRANCE ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2018?2030 (USD MILLION) 54
TABLE 34 FRANCE ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2018?2030 (USD MILLION) 55
TABLE 35 FRANCE ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018?2030 (USD MILLION) 55
TABLE 36 FRANCE ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018?2030 (USD MILLION) 56
TABLE 37 UK ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2018?2030 (USD MILLION) 56
TABLE 38 UK ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2018?2030 (USD MILLION) 56
TABLE 39 UK ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2018?2030 (USD MILLION) 57
TABLE 40 UK ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018?2030 (USD MILLION) 57
TABLE 41 UK ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018?2030 (USD MILLION) 58
TABLE 42 ITALY ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2018?2030 (USD MILLION) 58
TABLE 43 ITALY ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2018?2030 (USD MILLION) 59
TABLE 44 ITALY ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2018?2030 (USD MILLION) 59
TABLE 45 ITALY ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018?2030 (USD MILLION) 59
TABLE 46 ITALY ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018?2030 (USD MILLION) 60
TABLE 47 SPAIN ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2018?2030 (USD MILLION) 61
TABLE 48 SPAIN ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2018?2030 (USD MILLION) 61
TABLE 49 SPAIN ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2018?2030 (USD MILLION) 61
TABLE 50 SPAIN ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018?2030 (USD MILLION) 62
TABLE 51 SPAIN ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018?2030 (USD MILLION) 62
TABLE 52 REST OF EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE, 2018?2030 (USD MILLION) 63
TABLE 53 REST OF EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE, 2018?2030 (USD MILLION) 63
TABLE 54 REST OF EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE, 2018?2030 (USD MILLION) 64
TABLE 55 REST OF EUROPE ANTI-ACNE DERMAL PATCH MARKET, FOR CHEMICAL BASED, BY TYPE, 2018?2030 (USD MILLION) 64
TABLE 56 REST OF EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL, 2018?2030 (USD MILLION) 64
TABLE 57 MAJOR PLAYERS IN THE EUROPE ANTI-ACNE DERMAL PATCH MARKET 65
TABLE 58 MOST ACTIVE PLAYER IN THE EUROPE ANTI-ACNE DERMAL PATCH MARKET 68
TABLE 59 PRODUCT APPROVAL AND PRODUCT LAUNCHES 69
TABLE 60 ACQUISITION 69
TABLE 61 3M: PRODUCTS OFFERED 72
TABLE 62 ECOFEMINII LTD.: PRODUCTS OFFERED 74
TABLE 63 AVALON NATURAL PRODUCTS, INC.: PRODUCTS OFFERED 75
TABLE 64 ZITSTICKA: PRODUCTS OFFERED 77
TABLE 65 ZITSTICKA: KEY DEVELOPMENTS 77
TABLE 66 MARIO BADESCU SKIN CARE, INC.: PRODUCTS OFFERED 79
TABLE 67 CHURCH & DWIGHT CO., INC.: PRODUCTS OFFERED 81
TABLE 68 CHURCH & DWIGHT CO., INC: KEY DEVELOPMENTS 81
TABLE 69 STARFACE: PRODUCTS OFFERED 83
TABLE 70 PEACE OUT LLC: PRODUCTS OFFERED 85
TABLE 71 COSRX: PRODUCTS OFFERED 87
TABLE 72 PEACH & LILLY: PRODUCTS OFFERED 88

?

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

Market Research Future社の医療分野での最新刊レポート

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Market Research Future社はどのような調査会社ですか?


マーケットリサーチフューチャー(Market Research Future)は世界市場を幅広く調査し、主要分野、地域、国レベルの調査レポートを出版しています。   下記分野については、分野毎に専... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20 10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る